← Back to Resource Library
Migraine Symptoms

Why Do Migraines Cause Nausea and Vomiting?

By Lex Darrow, Lead Editor, MigraClarity

For many people with migraine, the headache is not the worst part. It is the nausea. The relentless, wave-like feeling that makes it impossible to eat, difficult to take medication, and exhausting to simply exist during an attack. For some, vomiting follows. For others, the nausea persists without relief for hours, an unwanted companion to pain that is already severe.

Nausea is not a side effect of migraine pain. It is a direct neurological symptom produced by the same biological cascade that causes the headache. Understanding why it happens helps explain why it is so difficult to treat, why certain medications work better than others during an attack, and what practical strategies can reduce its impact.

How Common Is It

Nausea is among the most prevalent symptoms of migraine. Research consistently finds that it occurs in the majority of migraine attacks across patient populations. A large epidemiological study published in Neurology found that nausea was present in approximately seventy-three percent of migraine attacks, making it the most common associated symptom after head pain itself. Vomiting occurs in approximately twenty-nine percent of attacks.

The International Headache Society includes nausea or vomiting as one of the diagnostic criteria for migraine, recognizing it not as a peripheral complaint but as a defining feature of the condition.

The Neurology Behind the Nausea

The connection between migraine and nausea runs through several overlapping pathways. The most significant involves the brainstem, which houses the primary vomiting center of the brain. These regions receive input from the trigeminal nerve system that drives migraine pain, from the vestibular system that controls balance, and from the gut via the vagus nerve. When the trigeminal cascade of a migraine attack activates these brainstem regions, nausea and vomiting follow.

The same neuropeptide that drives migraine pain, calcitonin gene-related peptide (CGRP), has receptors throughout the gastrointestinal system and may contribute directly to nausea through peripheral mechanisms as well as central ones.

Serotonin plays a significant role. During a migraine attack, serotonin levels in the bloodstream fluctuate, and serotonin receptors in the gut are activated in ways that contribute to nausea, reduced gastric motility, and gastric stasis.

Gastric Stasis and the Medication Problem

One of the most clinically significant consequences of migraine-associated nausea is gastric stasis, the slowing or cessation of normal stomach emptying during an attack. Research has demonstrated that gastric motility decreases measurably during migraine, meaning that oral medications taken during an attack may sit in the stomach for much longer than normal before being absorbed into the bloodstream.

This has direct implications for treatment. An oral triptan or analgesic that would normally be absorbed within thirty to sixty minutes may take several hours to reach therapeutic levels in the bloodstream during an attack with significant gastric stasis. By the time the medication is absorbed, the attack may have progressed to a stage where it is less responsive to treatment.

This is one of the reasons why early treatment of migraine, before significant nausea and gastric stasis develop, produces better outcomes. It is also why non-oral medication delivery routes, including nasal sprays, injections, and dissolving tablets, are often more effective during attacks with prominent nausea.

Anti-Nausea Medications in Migraine Treatment

Antiemetic medications serve two purposes in migraine treatment. They directly address the nausea symptom. They also improve gastric motility, which enhances the absorption of co-administered oral migraine medications.

Metoclopramide and prochlorperazine are among the most commonly used antiemetics in acute migraine treatment. Both work in part by blocking dopamine receptors and promoting gastric motility. Research has shown that metoclopramide not only reduces nausea but also has some direct analgesic effect in migraine.

Ondansetron, a serotonin receptor antagonist, is also used in migraine management, particularly for people with severe vomiting. It addresses the serotonergic component of migraine nausea without the dopamine-related side effects of metoclopramide and prochlorperazine.

Practical Strategies During an Attack

Beyond medication, several practical approaches can help manage nausea during a migraine attack. Small amounts of ginger, whether as tea, candied ginger, or ginger chews, have some evidence for reducing nausea and are safe to use alongside migraine medications. Cold packs applied to the neck or forehead provide sensory input that some people find reduces nausea intensity. Staying in a cool, dark, quiet environment reduces the sensory overload that can amplify nausea.

Avoiding strong smells during an attack is important for many people. Osmophobia, sensitivity to odors, is closely linked to migraine nausea, and exposure to perfumes, cooking smells, or other strong scents during an attack can intensify nausea significantly.

Hydration is important but challenging during an attack with significant nausea. Small, frequent sips of cold water or electrolyte-containing fluids are generally better tolerated than larger quantities.

When Nausea Is the Most Disabling Symptom

For some people with migraine, nausea is more disabling than the headache itself. It prevents eating, disrupts medication timing, and makes resting difficult. This reality should be communicated to the treating clinician, because it directly influences treatment selection.

A treatment plan that focuses only on pain relief without addressing nausea is incomplete for people in whom nausea is a primary driver of disability. Proactive antiemetic use, non-oral medication delivery, and strategies to reduce gastric stasis should all be part of the conversation.

Sources

Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States. Headache. 2001.

Aurora SK, Kori SH, Barrodale P, et al. Gastric stasis in migraine. Headache. 2006.

Tfelt-Hansen P, Koehler PJ. History of the use of ergotamine and dihydroergotamine in migraine. Cephalalgia. 2008.

American Migraine Foundation. Nausea and Vomiting Associated with Migraine. americanmigrainefoundation.org

Related Articles

Tracking your migraines changes everything. MigraClarity helps you log attacks, identify triggers, monitor medications, and track sleep and hydration — then generates a provider-ready report you can bring to your next appointment. Create your free account and start building a clearer picture of your migraine pattern today.

Create Your Free Account

The information in this article is intended for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional or licensed physician before making any decisions about your health, medications, or treatment. MigraClarity is not a medical provider and nothing on this site should be used as a substitute for professional medical care.

← Back to Resource Library